跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
pneumococcal vaccine
首页
药物
pneumococcal vaccine
pneumococcal vaccine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Multivalent pneumococcal polysaccharide-protein conjugate composition
CN 104815327 A
申请人: WYETH LLC
优先权: 2005
CN
EP
US
21 件公开
CN 105079800 A
申请人: WYETH CORP
优先权: 2006
CN
US
8 件公开
US 7955605 B2
申请人: WYETH LLC
优先权: 2006
CN
US
6 件公开
US 7709001 B2
申请人: WYETH LLC
优先权: 2006
US
4 件公开
US 9981029 B2
申请人: SK CHEMICALS CO LTD
优先权: 2012
CN
US
2 件公开
CN 104837504 A
申请人: SK CHEMICALS CO LTD
优先权: 2013
CN
US 2024408221 A1
申请人: WYETH LLC
优先权: 2024
US
COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
EP 3720483 B1
申请人: MERCK SHARP & DOHME LLC
优先权: 2017
CN
EP
US
WO
12 件公开
EP 3897705 A2
申请人: MERCK SHARP & DOHME
优先权: 2018
CN
EP
US
WO
9 件公开
PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
EP 3585803 B1
申请人: MERCK SHARP & DOHME LLC
优先权: 2017
CN
EP
US
WO
8 件公开
CN 110996992 A
申请人: MERCK SHARP & DOHME
优先权: 2017
CN
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE
EP 3130348 A1
申请人: GLAXOSMITHKLINE BIOLOGICALS SA
优先权: 2005
EP
US
8 件公开
Pneumococcal dosing regimen
US 12226470 B2
申请人: WYETH LLC
优先权: 2006
US
6 件公开
POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE COMPONENT AND APPLICATION THEREOF
EP 4512419 A4
申请人: SHANGHAI REINOVAX BIOLOGICS CO LTD
优先权: 2022
CN
EP
US
WO
5 件公开
Method for selecting and producing vaccine components and vaccines based thereon
US 8142789 B2
申请人: LEENHOUTS CORNELIS JOHANNES
优先权: 2003
EP
US
5 件公开
PNEUMOCOCCAL VACCINE COMBINING SELECTED ALPHA HELICAL DOMAINS AND PROLINE RICH DOMAINS OF PNEUMOCOCCAL SURFACE PROTEIN A
EP 3548076 A2
申请人: UAB RES FOUND
优先权: 2016
CN
EP
US
WO
4 件公开
INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION
CN 105126097 A
申请人: NOVARTIS AG
优先权: 2005
CN
EP
US
4 件公开
US 9402915 B2
申请人: MARSHALL CAMERON JOHN
优先权: 2004
US
2 件公开
Pneumococcal surface proteins
US 12280098 B2
申请人: UNIV TOKYO
优先权: 2019
CN
EP
US
4 件公开
第 1 / 8 页
上一页
下一页
药物
反馈